Piloting a Peer-Driven Intervention Model to Increase Access and Adherence to Antiretroviral Therapy and HIV Care among Street-Entrenched HIV-Positive Women in Vancouver

被引:74
作者
Deering, Kathleen Nicole [1 ]
Shannon, Kate [1 ]
Sinclair, Hayley [1 ]
Parsad, Devi [1 ]
Gilbert, Erin [1 ]
Tyndall, Mark W. [1 ]
机构
[1] St Pauls Hosp, BC Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada
关键词
INJECTION-DRUG USERS; MEDICATION ADHERENCE; VIRAL SUPPRESSION; INHIBITOR THERAPY; CELL COUNT; HAART; MORTALITY; INFECTION; SERVICES; SURVIVAL;
D O I
10.1089/apc.2009.0022
中图分类号
R1 [预防医学、卫生学];
学科分类号
100235 [预防医学];
摘要
A peer-driven intervention (PDI) was developed to support uptake and adherence to highly active antiretroviral therapy (HAART) among women sex workers who use illicit substances in Vancouver, because uptake and adherence continues to be suboptimal. Trends of adherence were examined among women in this program by (1) exposure to the intervention and (2) risk behaviors including drug use and unstable housing. Between January 2007 and January 2008, 20 HIV-positive women were enrolled into the PDI on a rolling basis. PDI participation included weekly peer support meetings, a health advocate (buddy) system, peer outreach service, and onsite nursing care. Adherence was measured directly with pharmacy records (PR) and indirectly with self-report and viral load (VL) outcomes. Participants attended an average of 50 (21-70) PDI meetings. Overall self-reported adherence was high (92%) and most women (11) reported increased adherence from the first to the last 13 PDI meetings attended (average increase = 18%). The number of viral load tests <= 50 copies/mL increased by 40% from the pre-PDI period (1 year before enrollment), to the PDI period (duration enrolled). PR adherence and improvements in VL outcomes were higher among participants with greater housing instability and frequency of injecting/smoking drugs. Despite a very difficult environment to provide HIV care, there is evidence to suggest that the PDI may have had a positive impact on adherence outcomes. Although this would not predict long-term treatment success, the PDI approach to HIV treatment support is a promising program for women who might otherwise be excluded from treatment altogether.
引用
收藏
页码:603 / 609
页数:7
相关论文
共 32 条
[1]
Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression [J].
Bangsberg, David R. .
CLINICAL INFECTIOUS DISEASES, 2006, 43 (07) :939-941
[2]
Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population [J].
Bangsberg, DR ;
Hecht, FM ;
Charlebois, ED ;
Zolopa, AR ;
Holodniy, M ;
Sheiner, L ;
Bamberger, JD ;
Chesney, MA ;
Moss, A .
AIDS, 2000, 14 (04) :357-366
[3]
Beith A., 2006, Interventions to Improve Adherence to Antiretroviral Therapy: A Review of the Evidence
[4]
Practical and conceptual challenges in measuring antiretroviral adherence [J].
Berg, Karina M. ;
Arnsten, Julia H. .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2006, 43 :S79-S87
[5]
Broadhead RS, 1999, PUBLIC HEALTH, V113, P42
[6]
Increasing drug users' adherence to HIV treatment: results of a peer-driven intervention feasibility study [J].
Broadhead, RS ;
Heckathorn, DD ;
Altice, FL ;
van Hulst, Y ;
Carbone, M ;
Friedland, GH ;
O'Connor, PG ;
Selwyn, PA .
SOCIAL SCIENCE & MEDICINE, 2002, 55 (02) :235-246
[7]
Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG Adherence Instruments [J].
Chesney, MA ;
Ickovics, JR ;
Chambers, DB ;
Gifford, AL ;
Neidig, J ;
Zwickl, B ;
Wu, AW .
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2000, 12 (03) :255-266
[8]
Problem drinking and medication adherence among persons with HIV infection [J].
Robert L. Cook ;
Susan M. Sereika ;
Susan C. Hunt ;
William C. Woodward ;
Judith A. Erlen ;
Joseph Conigliaro .
Journal of General Internal Medicine, 2001, 16 (2) :83-88
[9]
Comparisons of causes of death and mortality rates among HIV-infected persons - Analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras [J].
Crum, NF ;
Riffenburgh, RH ;
Wegner, S ;
Agan, BK ;
Tasker, SA ;
Spooner, KM ;
Armstrong, AW ;
Fraser, S ;
Wallace, MR .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2006, 41 (02) :194-200
[10]
Diagnostic value of different adherence measures using electronic monitoring and virologic failure as reference standards [J].
Deschamps, Ann E. ;
De Geest, Sabina ;
Vandamme, Anne-Mieke ;
Bobbaers, Herman ;
Peetermans, Willy E. ;
Van Wijngaerden, Eric .
AIDS PATIENT CARE AND STDS, 2008, 22 (09) :735-743